ARTICLE | Company News
Novavax, Bill & Melinda Gates Foundation infectious news
October 5, 2015 7:00 AM UTC
The foundation awarded Novavax a grant worth up to $89 million to support a Phase III trial of RSV F Vaccine to protect infants from respiratory syncytial virus (RSV) infection via maternal immunizat...